Showing 541 - 560 results of 901 for search '"Alzheimers"', query time: 0.05s Refine Results
  1. 541

    Delaying Onset of Dementia: Are Two Languages Enough? by Morris Freedman, Suvarna Alladi, Howard Chertkow, Ellen Bialystok, Fergus I. M. Craik, Natalie A. Phillips, Vasanta Duggirala, Surampudi Bapi Raju, Thomas H. Bak

    Published 2014-01-01
    “…Although there were differences in results across studies, a common theme was the significant effect of language use history as one of the factors in determining the onset of Alzheimer’s disease. Moreover, the Hyderabad study extended the findings to frontotemporal dementia and vascular dementia.…”
    Get full text
    Article
  2. 542

    Trends for Clinical Trials on Medicinal Products for Neurological Disorders in Lithuania and Europe by Emilijus Žilinskas, Arūnas Vaitkevičius

    Published 2024-03-01
    “…The majority of the trials (363 (17.20%)) were clinical trials for Alzheimer’s disease and other dementias. During the period of 2012–2021, there was a significant decrease in the annual registration rate of clinical trials for Alzheimer’s disease and other dementias (R² = 0.751, p = 0.001) and an increase of clinical trials for myoneural junction and muscle diseases and motor neuron disease (R² = 0.582, p = 0.010 and R² = 0.635, p = 0.006, accordingly). …”
    Get full text
    Article
  3. 543

    Frontotemporal dementia: peculiarities of clinical variants by B. Klimbytė, A. Vaitkus

    Published 2021-12-01
    “…Conventional neuropsychological tests used in the diagnosis of Alzheimer’s disease are not sensitive enough to assess cognitive impairment in the frontal lobes. …”
    Get full text
    Article
  4. 544

    Medicinal Effect of Nutraceutical Fruits for the Cognition and Brain Health by Raj K. Keservani, Anil K. Sharma, Rajesh K. Kesharwani

    Published 2016-01-01
    “…The recent era is witnessing evaluation of medicinal and nutritional value of fruits and fruit juices for the management and prevention of brain diseases like headache stress, anxiety, hypertension, and Alzheimer’s and Parkinson’s diseases by the scientists and researchers worldwide. …”
    Get full text
    Article
  5. 545

    In Sickness and in Health: Perineuronal Nets and Synaptic Plasticity in Psychiatric Disorders by Harry Pantazopoulos, Sabina Berretta

    Published 2016-01-01
    “…Studies on schizophrenia, autism spectrum disorders, mood disorders, Alzheimer’s disease, and epilepsy point to the involvement of ECM molecules such as chondroitin sulfate proteoglycans, Reelin, and matrix metalloproteases, as well as their cell surface receptors. …”
    Get full text
    Article
  6. 546

    An Approach to Diagnostic Criteria for the Definition of Slight Cognitive Impairment by Julio Armas Castro, Mayra Rosa Carrasco García, Sussette Angell Valdés, Yanet López Mena

    Published 2009-12-01
    “…For years the term slight cognitive impairment has been used in literature as a transitional stage between normal aging and a slight Alzheimer’s disease and in conversion studies it has been associated to quantitative and qualitative alterations that support that support the hypothesis that slight cognitive impairment constitutes an early stage of dementia in most of the patients. …”
    Get full text
    Article
  7. 547

    Effect of Combined Antihypertensive and Lipid-Lowering Therapies on Cognitive Function: A New Treatment Strategy? by Ze-Min Kuang

    Published 2020-01-01
    “…Actively controlling potential risk factors from middle age may be important for Alzheimer’s disease (AD) prevention.…”
    Get full text
    Article
  8. 548

    Modal Logic, Probability and Machine Learning Systems for Metadata Extraction by Simone Cuconato

    Published 2024-12-01
    “…The result is a well-motivated system of probabilistic modal logic, that defines a probability distribution over possible worlds of the truth value of metadata extracted from precision medicine approach to Alzheimer’s disease articles through machine learning systems.…”
    Get full text
    Article
  9. 549

    COMBINATION OF MULTILAYER Ag-Al FOR OPTICAL BIOSENSOR BASED ON SURFACE PLASMON RESONANCE by Tan Tai Nguyen

    Published 2024-09-01
    “…This leads us to believe that the proposed SPR sensor can be used to detect biological targets during the clinical diagnosis of diseases, e.g., heart disease, Alzheimer’s disease, cardiovascular disease, and stroke. …”
    Get full text
    Article
  10. 550

    P2Y Receptors in Synaptic Transmission and Plasticity: Therapeutic Potential in Cognitive Dysfunction by Segundo J. Guzman, Zoltan Gerevich

    Published 2016-01-01
    “…The findings discussed here may explain how P2Y1 receptor activation during brain injury, hypoxia, inflammation, schizophrenia, or Alzheimer’s disease leads to an impairment of cognitive processes. …”
    Get full text
    Article
  11. 551

    Impact of Aging in Microglia-Mediated D-Serine Balance in the CNS by Sebastián Beltrán-Castillo, Jaime Eugenín, Rommy von Bernhardi

    Published 2018-01-01
    “…D-serine dysregulation promoted by microglia could have a role in age-related cognitive impairment and in the induction and progression of neurodegenerative processes like Alzheimer’s disease.…”
    Get full text
    Article
  12. 552

    Statistical identification of cell type-specific spatially variable genes in spatial transcriptomics by Lulu Shang, Peijun Wu, Xiang Zhou

    Published 2025-01-01
    “…Applied to five real datasets, Celina uncovers ct-SVGs associated with tumor progression and patient survival in lung cancer, identifies metagenes with unique spatial patterns linked to cell proliferation and immune response in kidney cancer, and detects genes preferentially expressed near amyloid-β plaques in an Alzheimer’s model.…”
    Get full text
    Article
  13. 553

    A Review of the Healthcare and Social Care Needs of the Older Prisoner Population in England and Wales by Paul Gavin, Cody Normitta Porter, Finley MacDonald

    Published 2024-12-01
    “…This paper provides an overview of the main challenges facing older prisoners in the context of their health and social care needs, including the development of mental health problems such as Alzheimer’s and dementia, as well as challenges related to mobility and engaging in structured activities in prison. …”
    Get full text
    Article
  14. 554

    The Role of Mitochondrial Damage-Associated Molecular Patterns in Chronic Neuroinflammation by Ekta Bajwa, Caitlin B. Pointer, Andis Klegeris

    Published 2019-01-01
    “…In this review, we highlight the mitochondrial DAMPs cytochrome c (CytC), mitochondrial transcription factor A (TFAM), and cardiolipin and explore their potential role in the central nervous system disorders including Alzheimer’s disease and Parkinson’s disease, which are characterized by neurodegeneration and chronic neuroinflammation.…”
    Get full text
    Article
  15. 555

    FAACOSE: A Fast Adaptive Ant Colony Optimization Algorithm for Detecting SNP Epistasis by Lin Yuan, Chang-An Yuan, De-Shuang Huang

    Published 2017-01-01
    “…We compared our method with other existing methods using synthetic datasets and applied the proposed method to Late-Onset Alzheimer’s Disease dataset. Our experimental results show that the proposed method outperforms other methods in epistasis detection, and the result of real dataset contributes to the research of mechanism underlying the disease.…”
    Get full text
    Article
  16. 556

    Cognitive Phenotypes, Brain Morphometry and the Detection of Cognitive Decline in Preclinical AD by Mark W. Jacobson, Linda K. McEvoy, Anders Dale, Christine Fennema-Notestine

    Published 2009-01-01
    “…Identifying a preclinical phase of Alzheimer’s Disease (PCAD) that is distinct from cognitive changes in healthy aging continues to be a major research focus. …”
    Get full text
    Article
  17. 557

    White Matter Injury in Central Nervous System Disorders by Zheng L, Wang X, Li P, Hao Y, Zhang H, Chen H, Zheng Z

    Published 2025-01-01
    “…In this article, we will briefly describe the structure and function of white matter, summarize the pathological changes of WMI, and focus on the molecular mechanisms and therapeutic research advances in WMI after ischemic stroke, cerebral hemorrhage, Alzheimer’s disease, and multiple sclerosis diseases.Keywords: white matter injury, central nervous system, oligodendrocytes, myelin…”
    Get full text
    Article
  18. 558

    Disruption in the Blood-Brain Barrier: The Missing Link between Brain and Body Inflammation in Bipolar Disorder? by Jay P. Patel, Benicio N. Frey

    Published 2015-01-01
    “…There has been growing evidence that BBB disruption is associated with brain inflammatory conditions such as Alzheimer’s disease and multiple sclerosis. Considering the increasing role of inflammation and oxidative stress in the pathophysiology of bipolar disorder (BD), here we propose a novel model wherein transient or persistent disruption of BBB integrity is associated with decreased CNS protection and increased permeability of proinflammatory (e.g., cytokines, reactive oxygen species) substances from the peripheral blood into the brain. …”
    Get full text
    Article
  19. 559

    Neurological and Neurobehavioral Disorders Associated with Toxoplasma gondii Infection in Humans by Maxwell A. Virus, Evie G. Ehrhorn, LeeAnna M. Lui, Paul H. Davis

    Published 2021-01-01
    “…Consequently, several studies have examined the link between T. gondii infection and diseases such as schizophrenia, epilepsy, depression, bipolar disorder, dysphoria, Alzheimer’s disease, Parkinson’s disease, and obsessive-compulsive disorder (OCD). …”
    Get full text
    Article
  20. 560

    Exploring environmental factors contributing to Parkinson’s disease in AfrAbian populations by Wael Mohamed

    Published 2024-12-01
    “…Neurological diseases, including neurodegenerative syndromes like Alzheimer’s disease, Parkinson’s disease, and motor neuron illnesses, have been increasingly seen and recorded in the scientific literature. …”
    Get full text
    Article